(BPMC) Blueprint Medicines complete technical analysis [charts+indicators] | Buy/Sell Blueprint Medicines | (BPMC) share price targets
Complete technical analysis of Blueprint Medicines (BPMC) by charts plus indicators, forecast predictions and share price targets for Blueprint Medicines (BPMC)
Blueprint Medicines trades in USA in Health Care sector.
Showing technical analysis as on 2024-06-21 View latest technical analysis
10 day averaged volume of Blueprint Medicines is 531340
Date | Daily Closing Price | Open | High | Low | Volume |
21 Fri Jun 2024 | 104.23 | 106.03 | 106.51 | 102.37 | 2.027 times |
20 Thu Jun 2024 | 105.21 | 105.81 | 107.20 | 103.15 | 0.81 times |
18 Tue Jun 2024 | 106.71 | 103.85 | 107.12 | 102.55 | 1.077 times |
18 Tue Jun 2024 | 106.71 | 103.85 | 107.12 | 102.55 | 1.077 times |
17 Mon Jun 2024 | 103.87 | 105.04 | 107.60 | 102.87 | 1.427 times |
14 Fri Jun 2024 | 105.55 | 104.44 | 106.86 | 103.49 | 0.874 times |
13 Thu Jun 2024 | 106.39 | 106.14 | 108.12 | 105.74 | 0.582 times |
12 Wed Jun 2024 | 106.14 | 107.54 | 108.78 | 104.46 | 1.255 times |
11 Tue Jun 2024 | 105.40 | 103.13 | 105.96 | 101.73 | 1.016 times |
10 Mon Jun 2024 | 104.03 | 102.40 | 104.41 | 100.67 | 1.367 times |
Stock of Blueprint Medicines (BPMC) has showed a significant fall. This could be a good time to exit from this stock.
My analysis of stock is bearish for shortterm, and stock might move down till 102.9 or till 100.8. Use a stoploss of 104.59 and if the stock hits stoploss, then it can shoot up till 106.29
Share price targets for Blueprint Medicines (BPMC)
Target Type | Value |
Downside Target | 72.24 |
Downside Target | 84.33 |
Downside Target | 90.85 |
Downside Target | 97.00 |
Downside Target | 102.55 |
Upside Target | 107.20 |
Upside Target | 107.60 |
Upside Target | 108.53 |
Upside Target | 108.78 |
Upside Target | 109.37 |
Upside Target | 111.02 |
Intraday share price targets for Blueprint Medicines (BPMC)
Target Type | Value |
Downside Intraday Target | 102 |
Downside Intraday Target | 99.77 |
Upside Intraday Target | 106.83 |
Upside Intraday Target | 109.43 |
Upside Intraday Target | 104.6 |
Weekly technical analysis of Blueprint Medicines (BPMC)
Date | Weekly Closing Price | Open | High | Low | Volume |
21 Fri Jun 2024 | 104.23 | 103.85 | 107.20 | 102.37 | 1.563 times |
18 Tue Jun 2024 | 106.71 | 105.04 | 107.60 | 102.55 | 0.491 times |
14 Fri Jun 2024 | 105.55 | 102.40 | 108.78 | 100.67 | 1.264 times |
07 Fri Jun 2024 | 103.34 | 106.43 | 109.37 | 100.81 | 0.89 times |
31 Fri May 2024 | 105.56 | 103.88 | 108.53 | 99.16 | 1.32 times |
Price has moved down this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Blueprint Medicines (BPMC)
Date | Monthly Closing Price | Open | High | Low | Volume |
21 Fri Jun 2024 | 104.23 | 106.43 | 109.37 | 100.67 | 0.605 times |
31 Fri May 2024 | 105.56 | 91.44 | 111.02 | 90.85 | 1.009 times |
30 Tue Apr 2024 | 91.34 | 95.00 | 97.00 | 84.33 | 0.835 times |
28 Thu Mar 2024 | 94.86 | 93.81 | 98.06 | 84.81 | 0.82 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Blueprint Medicines (BPMC)
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Blueprint Medicines stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Blueprint Medicines in short term but the sell signal is initial and weak.
Blueprint Medicines Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Blueprint Medicines in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Blueprint Medicines is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 105.22 and Blueprint Medicines (BPMC) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Blueprint Medicines stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Blueprint Medicines in short term but the sell signal is initial and weak.
Blueprint Medicines Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Blueprint Medicines in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Blueprint Medicines is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 105.22 and Blueprint Medicines (BPMC) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.